LigaChem Biosciences Inc.

KOSDAQ:A141080 Stock Report

Market Cap: ₩4.4t

LigaChem Biosciences Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Yong Kim

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership3.6%
Management average tenureno data
Board average tenureless than a year

Recent management updates

Recent updates

LigaChem Biosciences (KOSDAQ:141080) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway

Dec 21
LigaChem Biosciences (KOSDAQ:141080) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway

Risks Still Elevated At These Prices As LigaChem Biosciences Inc. (KOSDAQ:141080) Shares Dive 26%

Nov 29
Risks Still Elevated At These Prices As LigaChem Biosciences Inc. (KOSDAQ:141080) Shares Dive 26%

LigaChem Biosciences (KOSDAQ:141080) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway

Sep 09
LigaChem Biosciences (KOSDAQ:141080) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway

Here's Why LigaChem Biosciences (KOSDAQ:141080) Can Manage Its Debt Despite Losing Money

May 23
Here's Why LigaChem Biosciences (KOSDAQ:141080) Can Manage Its Debt Despite Losing Money

A Look At The Fair Value Of LegoChem Biosciences, Inc. (KOSDAQ:141080)

Mar 29
A Look At The Fair Value Of LegoChem Biosciences, Inc. (KOSDAQ:141080)

What Kind Of Shareholders Hold The Majority In LegoChem Biosciences, Inc.'s (KOSDAQ:141080) Shares?

Jan 28
What Kind Of Shareholders Hold The Majority In LegoChem Biosciences, Inc.'s (KOSDAQ:141080) Shares?

Estimating The Fair Value Of LegoChem Biosciences, Inc. (KOSDAQ:141080)

Dec 07
Estimating The Fair Value Of LegoChem Biosciences, Inc. (KOSDAQ:141080)

CEO

Yong Kim (68 yo)

no data

Tenure

Mr. Yong Zu Kim serves as the Chief Executive Officer, President and Director at LigaChem Biosciences Inc. (formerly known as LegoChem Biosciences, Inc.). Mr. Kim has of experience in drug discovery and de...

Board Members

NamePositionTenureCompensationOwnership
Yong Kim
CEO, President & Directorno datano data3.57%
₩ 158.2b
Sejin Park
CFO, COOno datano data0.50%
₩ 22.1b
Morris Rosenberg
Member of Scientific Advisory Boardno datano datano data
Robert Lutz
Member of Scientific Advisory Boardno datano datano data
Hyung-Seok Kim
Directorless than a yearno data0.0041%
₩ 181.4m
Rakesh Dixit
Member of Scientific Advisory Boardno datano datano data
Lawrence Geiter
Member of Scientific Advisory Boardno datano datano data
In-Cheol Heo
Directorless than a yearno datano data
Seo Won Dam
Directorless than a yearno datano data
Lee Seungho
Independent Outside Directorless than a yearno datano data

0.8yrs

Average Tenure

63yo

Average Age

Experienced Board: A141080's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/19 02:59
End of Day Share Price 2025/01/17 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

LigaChem Biosciences Inc. is covered by 8 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mujinn LeeCape Investment & Securities Co., Ltd.
Seohyun LeeCitigroup Inc
Jisoo LeeDAOL Investment & Securities Co., Ltd.